Acetyl-L-carnitine (ALC), N-acetyl-L-cysteine (NAC) and α-lipoic acid (ALA)
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
20
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Culture Media
Conditions
Culture Media, Blastocyst, Antioxidants, Embryo, Human
Trial Timeline
Nov 1, 2016 → Feb 1, 2018
NCT ID
NCT02971878About Acetyl-L-carnitine (ALC), N-acetyl-L-cysteine (NAC) and α-lipoic acid (ALA)
Acetyl-L-carnitine (ALC), N-acetyl-L-cysteine (NAC) and α-lipoic acid (ALA) is a pre-clinical stage product being developed by Vitrolife AB for Culture Media. The current trial status is completed. This product is registered under clinical trial identifier NCT02971878. Target conditions include Culture Media, Blastocyst, Antioxidants.
Hype Score Breakdown
Clinical
5
Activity
2
Company
7
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02971878 | Pre-clinical | Completed |